The artificial heart valve maker will settle allegations it deliberately structured its deal to acquire JC Medical to sidestep a Hart-Scott-Rodino review.
Source: MedTech Dive
You may also like
Copay Assistance Is Meant To Defray Patient Drug...
Patients Face a Thicket of Red Tape Trying To Maintain...
Affordable Care Act Insurers Want More Premium...
As GOP Cries Fraud, Newsom Backs Medicaid Spending on...
Expert insights to transform your evidence generation...
Freenome colorectal cancer test data improve on...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.